Australia markets closed

Xenon Pharmaceuticals Inc. (XENE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
39.50-1.59 (-3.87%)
At close: 04:00PM EDT
39.50 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
148,643
57,242
175,688
45,009
Other short-term investments
489,439
534,845
376,086
131,988
Total cash
638,082
592,087
551,774
176,997
Net receivables
874
986
2,765
1,822
Other current assets
6,006
7,225
4,481
-
Total current assets
644,962
600,298
559,020
181,783
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
30,097
25,611
25,872
22,034
Accumulated depreciation
-11,251
-8,705
-13,350
-15,154
Net property, plant and equipment
18,846
16,906
12,522
6,880
Equity and other investments
292,792
128,682
0
-
Total non-current assets
319,836
153,848
12,987
7,403
Total assets
964,798
754,146
572,007
189,186
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
8,598
8,491
3,824
3,041
Accrued liabilities
9,951
7,900
3,953
4,974
Deferred revenues
-
-
0
3,642
Total current liabilities
27,273
22,702
14,322
14,781
Non-current liabilities
Deferred revenues
-
-
-
0
Total non-current liabilities
9,604
9,947
7,652
3,050
Total liabilities
36,877
32,649
21,974
17,831
Stockholders' equity
Common stock
1,436,374
1,065,136
790,902
405,480
Retained earnings
-665,140
-482,747
-357,374
-278,492
Accumulated other comprehensive income
-77
-3,000
-990
-990
Total stockholders' equity
927,921
721,497
550,033
171,355
Total liabilities and stockholders' equity
964,798
754,146
572,007
189,186